Thomson Medical Group Past Earnings Performance
Past criteria checks 1/6
Thomson Medical Group has been growing earnings at an average annual rate of 46%, while the Healthcare industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 12.8% per year. Thomson Medical Group's return on equity is 0.3%, and it has net margins of 0.1%.
Key information
46.0%
Earnings growth rate
46.0%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 12.8% |
| Return on equity | 0.3% |
| Net Margin | 0.1% |
| Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
Recent updates
Earnings Troubles May Signal Larger Issues for Thomson Medical Group (SGX:A50) Shareholders
Sep 02
Calculating The Fair Value Of Thomson Medical Group Limited (SGX:A50)
Apr 01Should You Think About Buying Thomson Medical Group Limited (SGX:A50) Now?
Dec 16Here's Why Thomson Medical Group (SGX:A50) Has A Meaningful Debt Burden
Aug 31We Ran A Stock Scan For Earnings Growth And Thomson Medical Group (SGX:A50) Passed With Ease
Apr 24Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet
Mar 27Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet
Nov 22Should You Be Adding Thomson Medical Group (SGX:A50) To Your Watchlist Today?
Sep 30Market Participants Recognise Thomson Medical Group Limited's (SGX:A50) Earnings
Sep 03These 4 Measures Indicate That Thomson Medical Group (SGX:A50) Is Using Debt Reasonably Well
Feb 26We Think Thomson Medical Group (SGX:A50) Can Stay On Top Of Its Debt
Oct 21We Think Thomson Medical Group (SGX:A50) Has A Fair Chunk Of Debt
Mar 27Eng Lim Just Bought A Sprinkling of Shares In Thomson Medical Group Limited (SGX:A50)
Feb 20
Should You Take Comfort From Insider Transactions At Thomson Medical Group Limited (SGX:A50)?
Jan 27Reflecting on Thomson Medical Group's (SGX:A50) Share Price Returns Over The Last Year
Dec 23Is Thomson Medical Group (SGX:A50) Using Too Much Debt?
Nov 27Revenue & Expenses Breakdown
How Thomson Medical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 24 | 387 | 1 | 0 | 0 |
| 30 Sep 24 | 371 | 8 | 0 | 0 |
| 30 Jun 24 | 356 | 15 | 0 | 0 |
| 31 Mar 24 | 351 | 16 | 0 | 0 |
| 31 Dec 23 | 345 | 16 | 0 | 0 |
| 30 Sep 23 | 353 | 26 | 0 | 0 |
| 30 Jun 23 | 361 | 37 | 0 | 0 |
| 31 Mar 23 | 370 | 50 | 0 | 0 |
| 31 Dec 22 | 379 | 64 | 0 | 0 |
| 30 Sep 22 | 359 | 59 | 0 | 0 |
| 30 Jun 22 | 339 | 54 | 0 | 0 |
| 31 Mar 22 | 304 | 36 | 0 | 0 |
| 31 Dec 21 | 269 | 19 | 0 | 0 |
| 30 Sep 21 | 255 | 16 | 0 | 0 |
| 30 Jun 21 | 240 | 14 | 0 | 0 |
| 31 Mar 21 | 228 | -38 | 0 | 0 |
| 31 Dec 20 | 215 | -89 | 0 | 0 |
| 30 Sep 20 | 215 | -94 | 0 | 0 |
| 30 Jun 20 | 216 | -99 | 0 | 0 |
| 31 Dec 19 | 230 | 1 | 0 | 0 |
| 30 Sep 19 | 227 | 2 | 0 | 0 |
| 30 Jun 19 | 222 | 7 | 0 | 0 |
| 31 Mar 19 | 218 | 9 | 0 | 0 |
| 31 Dec 18 | 216 | 11 | 0 | 0 |
| 30 Sep 18 | 212 | 10 | 0 | 0 |
| 30 Jun 18 | 208 | 14 | 0 | 0 |
| 31 Mar 18 | 204 | 15 | 0 | 0 |
| 31 Dec 17 | 201 | 16 | 0 | 0 |
| 31 Aug 17 | 199 | 33 | 34 | 0 |
| 31 Aug 16 | 193 | 27 | 34 | 0 |
| 31 Aug 15 | 177 | 25 | 32 | 0 |
Quality Earnings: A50 has a large one-off gain of SGD25.5M impacting its last 12 months of financial results to 31st December, 2024.
Growing Profit Margin: A50's current net profit margins (0.1%) are lower than last year (4.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A50's earnings have grown significantly by 46% per year over the past 5 years.
Accelerating Growth: A50's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A50 had negative earnings growth (-96.7%) over the past year, making it difficult to compare to the Healthcare industry average (-20.3%).
Return on Equity
High ROE: A50's Return on Equity (0.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 05:35 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Thomson Medical Group Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lih Rui Tan | DBS Bank Ltd |
| Eric Ong | Maybank Research Pte. Ltd. |